🇺🇸 FDA
Patent

US 11713353

Single-domain antibodies and variants thereof against PD-1

granted A61KA61K2039/505

Quick answer

US patent 11713353 (Single-domain antibodies and variants thereof against PD-1) held by Nanjing Legend Biotech Co., Ltd expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nanjing Legend Biotech Co., Ltd
Grant date
Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505